Concurrent Chemoradiotherapy Using Intensity Modulated Radiotherapy (IMRT) & Docetaxel-cisplatin (or Carboplatin) Followed by Adjuvant Chemotherapy for Inoperable Stage III Non-small-cell Lung Cancer

by lowes1 on October 9, 2013

Condition:   Lung Neoplasms
Interventions:   Drug: DOCETAXEL;   Radiation: Intensity Modulated Radiotherapy (IMRT);   Drug: CISPLATIN
Sponsors:   Sanofi;   Sanofi
Recruiting – verified December 2012

View full post on ClinicalTrials.gov: “Lung Neoplasms” | updated in the last 30 days

Leave a Comment

Previous post:

Next post: